More than 593,000 asthma inhalers in the United States have been recalled because of a problem that could cause them to deliver less medication than intended.
An FDA document indicates the reason for the recall is a “defective delivery system” due to a leak in the Ventolin inhalers. Reuters reports drugmaker GSK is trying to figure out what caused the problem after an increasing number of complaints, and is pulling the inhalers from hospitals, pharmacies, retailers and wholesalers.
GSK says patients using the inhalers are not in danger, so they don’t need to return the product.
The recalled inhalers have a lot number of 6ZP9848, 6ZP0003 or 6ZP9944 and expire in March or April of 2018.